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Abstract
Cationic amino acid transporters (CAT) are important regulators of NOS2 and ARG1 activity because they regulate L-arginine
availability. However, their role in the development of Th1/Th2 effector functions following infection has not been
investigated. Here we dissect the function of CAT2 by studying two infectious disease models characterized by the
development of polarized Th1 or Th2-type responses. We show that CAT22/2 mice are significantly more susceptible to the
Th1-inducing pathogen Toxoplasma gondii. Although T. gondii infected CAT22/2 mice developed stronger IFN-c responses,
nitric oxide (NO) production was significantly impaired, which contributed to their enhanced susceptibility. In contrast,
CAT22/2 mice infected with the Th2-inducing pathogen Schistosoma mansoni displayed no change in susceptibility to
infection, although they succumbed to schistosomiasis at an accelerated rate. Granuloma formation and fibrosis,
pathological features regulated by Th2 cytokines, were also exacerbated even though their Th2 response was reduced.
Finally, while IL-13 blockade was highly efficacious in wild-type mice, the development of fibrosis in CAT22/2 mice was
largely IL-13-independent. Instead, the exacerbated pathology was associated with increased arginase activity in fibroblasts
and alternatively activated macrophages, both in vitro and in vivo. Thus, by controlling NOS2 and arginase activity, CAT2
functions as a potent regulator of immunity.
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Introduction
Tissue macrophages comprise a heterogeneous population of
cells, recently separated into three major categories based on their
unique functional capabilities. The TH2 cytokines IL-4 and IL-13
trigger a characteristic ‘alternative’ state of activation in macro-
phages that is distinct from the ‘classical’ TH1-type activation by
IFN-c or deactivation phenotype associated with IL-10 and TGF-
b [1]. In contrast to classically activated macrophages (CAMø),
which regulate cellular immunity to intracellular pathogens,
alternatively-activated macrophages (AAMø) are associated with
chronic helminth infections and allergic disease [2,3,4]. AAMø’s
participate in humoral immune responses, facilitate clearance and
presentation of antigens, and regulate the important process of
tissue repair [1,5].
In the murine model of schistosomiasis, mice chronically
infected with Schistosoma mansoni develop severe liver pathology
characterized by the formation of eosinophil-rich granulomas and
fibrosis, which leads to portal hypertension, bleeding from
collateral vessels, and ultimately death [6]. As with many helminth
infections the immune response to S. mansoni is TH2-biased [7].
Consequently, AAMø’s are the major macrophage subpopulation
observed in schistosomiasis [8,9], with recent studies suggesting
their development is critical to the long-term survival of the
infected host [10]. Although the exact role of AAMø’s in
inflammation and fibrosis remains unclear, numerous studies
including our own have suggested they are important regulators of
wound healing. This hypothesis is based on the observation that
AAMø’s express a number of genes known to be involved in cell
proliferation and collagen synthesis, most prominent being the
enzyme arginase-1 (Arg-1) [2,9,11,12,13,14].
In contrast to iNOS, a widely investigated enzyme critically
involved in many aspects of host immunity [15], much less is
known about the role of arginase in infectious disease models [16].
Although it is known that arginases can antagonize NO synthesis
by competing for L-arginine [17,18,19], the inducible Arg-1
isoform is believed to regulate other important functions as well.
One of the major products of arginase is L-ornithine, a precursor
in the production of polyamines and proline, which control cell
proliferation and collagen production, respectively [16,19]. It is
thought that extracellular L-ornithine and L-proline, secreted from
arginase expressing cells (AAMø’s), are transported into fibro-
blasts, where they subsequently become incorporated into collagen
[20]. Therefore, Arg-1 expressing cells have been hypothesized to
be critical regulators of fibrosis. Thus, a better understanding of
the mechanisms regulating Arg-1 activity could reveal novel
strategies to control fibroproliferative diseases.
PLoS Pathogens | www.plospathogens.org 1 2008 | Volume 4 | Issue 3 | e1000023
Since extracellular L-arginine is required for sustained NO and
L-ornithine production [21], mechanisms controlling L-arginine
transport may critically regulate iNOS and Arg-1 activity. Among
the transport systems that facilitate L-arginine uptake, system y+ is
considered to be the major L-arginine transporter in most cells and
tissues [22]. Encoded by the solute carrier 7a1-3 (Slc7a1-3) family
of genes, y+ is a Na+-independent high affinity amino acid
transport system. CAT2 is the most dynamically regulated of the
three transporters, with CAT1 operating as the product of a
constitutively expressed ‘‘housekeeping’’ gene and CAT3 ex-
pressed primarily in the brain [23,24]. Several pro-inflammatory
mediators including LPS can regulate the expression of CAT2;
thus, it likely functions as the key L-arginine transporter during
inflammatory responses. Recent studies with CAT2-deficient mice
showed sustained NO production in macrophages is dependent on
CAT2 [25]. Thus, it appears to be the essential L-arginine
transporter in macrophages. However, while CAT2 has been
studied in the context of iNOS activity [25], no studies have
addressed its role in the regulation of Arg-1 activity following
infection.
To elucidate the function of the Slc7a2 gene in vivo, we
infected CAT22/2 mice with either Schistosoma mansoni or
Toxoplasma gondii; pathogens that induce highly polarized Th2
and Th1 responses, respectively [7]. Strikingly, following
infection with S. mansoni, CAT22/2 mice developed granulomas
that were 3- to 4-times larger than WT and hepatic fibrosis (a
feature of severe disease) was significantly exacerbated in
chronically infected mice [26,27,28,29], indicating a general
worsening of Th2-associated pathologies in the absence of CAT2.
The CAT22/2 mice were also more susceptible to T. gondii
infection, demonstrating that CAT2 is critical for the develop-
ment of protective Th1-dependent immunity. Thus, these studies
identify CAT2 as a powerful regulator of TH1 and TH2 effector
responses, which may have major implications for a variety of
infectious diseases.
Results
CAT2 suppresses pulmonary granuloma associated
inflammation and fibrosis
To determine whether CAT2 plays a regulatory role during an
acute Th2 response, we exploited the S. mansoni pulmonary
granuloma model [30]. In this model, schistosome eggs are
delivered to the lungs of mice via tail vein injection. The eggs are
deposited in the pulmonary vasculature where they induce an
eosinophil rich, CD4+ Th2 cell-dependent granulomatous re-
sponse [7]. Wild-type (WT) and CAT22/2 mice were sensitized
and challenged with 5000 live S. mansoni eggs and on day 4 and 7
post-challenge, animals were sacrificed and the effects of CAT2
deficiency were examined microscopically in the lung. Although
there were no significant differences in granuloma size or
composition on day 4, the CAT22/2 mice displayed an average
37% increase in granuloma size on day 7 (Fig. 1A), the peak of the
granulomatous response [31]. The increase in peak granuloma size
was also associated with significant picrosirius red staining of
histological sections (Fig. 1B), providing evidence of increased
fibrosis in the CAT22/2 lung.
Author Summary
Recent studies conducted with amino transporter Slc7a2-
deficient mice (CAT2) demonstrated that NOS2 activity in
macrophages is regulated by CAT2. NOS2, which synthe-
sizes nitric oxide, regulates numerous important activities,
including resistance to infectious organisms, tumor devel-
opment, and autoimmune diseases. It also competes with
the enzyme Arginase-1 (Arg1) for the common substrate L-
arginine. However, the role CAT2 in the regulation of Arg1
activity has not been previously examined. Therefore, we
infected CAT2-deficient mice with the helminth parasite
Schistosoma mansoni or with the protozoan pathogen
Toxoplasma gondii, two organisms that trigger highly
divergent host immune responses. Strikingly, following
infection with S. mansoni, CAT22/2 mice developed
parasite egg–induced lesions in the liver that were 3 to 4
times larger than wild type and hepatic fibrosis (a feature
of severe schistosomiasis) was exacerbated, indicating a
general worsening of disease in the absence of CAT2. The
CAT22/2 mice were also more susceptible to T. gondii
infection, demonstrating that CAT2 is critical for the
development of protective cell-mediated immunity. Thus,
these studies identify CAT2 as a powerful regulator of host
immune responses, which may have major implications for
a variety of infectious, inflammatory, and autoimmune
diseases.
Figure 1. CAT22/2 mice develop larger pulmonary granulomas and fibrosis is increased. WT C57BL/6 (N = 5) and CAT22/2 (N = 5) mice
were sensitized i.p. with S. mansoni eggs and then challenged 2 weeks later i.v. with 5000 live eggs. Mice were sacrificed on days 4 and 7 post-
challenge and granuloma volume (A) and fibrosis (B) was quantified from Giemsa (A) and Picrosirius Red (B) stained lung sections. Statistically
significant differences are shown. The experiment was repeated a total of three times with similar results.
doi:10.1371/journal.ppat.1000023.g001
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Liver granuloma formation is exacerbated in S. mansoni
infected CAT22/2 mice
To explore the role of CAT2 during a chronic Th2-driven
inflammatory response, WT and CAT22/2 mice were infected
with S. mansoni cercariae and the granulomatous response was
examined in the liver 8, 12, and 24 weeks post-infection. As
expected, peak granuloma size was observed at the acute time
point (wk 8), with subsequent down-modulation in granuloma
formation in chronically infected (wk 12–24) animals (Fig. 2A).
When the responses in WT and CAT22/2 mice were compared,
however, it was clear that the CAT22/2 mice developed
granulomas 2- to 3-times larger than WT at all time points
(Fig. 2A). There was also a small but significant increase in tissue
eosinophils on wk 12 (Fig. 2B) and a consistent increase in mast
cells in the CAT22/2 granulomas (Fig. 2C). The representative
photomicrographs shown in panels 2D (WT) and 2E (CAT22/2)
illustrate the exacerbated inflammatory response in the CAT22/2
liver. When infected with a high dose of parasites, the CAT22/2
mice also succumbed significantly faster thanWT animals (Fig. 2F).
However, at low doses, the survival of CAT22/2 was not
significantly different from WT through at least 24 wk of infection
(not shown).
The progression of liver fibrosis is accelerated in S.
mansoni infected CAT22/2 mice
Liver fibrosis is the primary cause of chronic morbidity in S.
mansoni infections [32]. To determine whether CAT2 regulates
tissue fibrogenesis, liver tissue was taken at various time points
post-infection and collagen content was measured as hydroxypro-
line [33]. Although both groups developed significant fibrosis,
hydroxyproline levels were markedly increased in the CAT22/2
livers, particularly at the chronic time points (Fig. 3A, 3B).
Collagen deposition was also examined histologically with
Masson’s trichrome (Figs. 3C and 3D) and picrosirius red stains
(not shown), and thick bands of collagen were seen throughout the
livers of the infected CAT22/2 mice. In contrast, collagen
deposition was primarily in areas surrounding the granulomas in
WT animals.
Serum AST (SGOT) and ALT (SGPT) levels were similarly
increased in both groups following infection (Fig. 4A, 4B),
indicating there was no evidence of significant egg-induced
hepatotoxicity in the CAT22/2 animals. In fact, AST/ALT levels
were slightly reduced in the CAT22/2 mice at the 8 wk time
point. However, the CAT22/2 mice displayed significant
hepatomegaly, particularly at the acute and early chronic time
points (Fig. 4C). There was also marked splenomegaly in the
absence of CAT2 (data not shown). Thus, in contrast to the
enhanced liver toxicity observed in IL-42/2, IL-4Ra2/2, and
LysMCreIL-4R2/2 mice [10,29,34], CAT22/2 mice developed
significant liver fibrosis, portal hypertension, and collateral vessels,
which are features of severe hepatosplenic disease.
Importantly, the increased pathological responses in the
CAT22/2 mice were not attributed to differences in parasite
burden since similar numbers of eggs and paired adult parasites
were found in the tissues of both groups at all time points (Table
S1).
Th2 cytokine production is impaired in CAT22/2 mice
Granuloma formation and fibrosis are tightly controlled by the
egg-induced Th2 response [5,7]. Therefore, to determine whether
local or systemic changes in Th2 cytokine production were
responsible for the severe pathological reactions in CAT22/2
mice, granuloma-associated lymphocytes were isolated from the
livers of individual mice (wk 8) and IL-5, IL-13, and IFN-c
production was assayed by intracellular cytokine staining (ICS).
Surprisingly, despite displaying a significant increase in pathology,
the frequency of IL-5 and IL-13-producing CD4+ T cells was
markedly reduced in the livers of infected CAT22/2 mice
(Fig. 5A). IL-13 production was also reduced in the non-CD4+
T cell population (Fig. 5B). The reduction in type-2 cytokines did
not result from an increased type-1 response because the
frequency of IFN-c producing cells (CD4+ and CD42 cells) was
also reduced in the CAT22/2 livers, but not to the same
magnitude as the type-2 cytokine producing cells.
We also isolated RNA from the liver and examined IFN-c, IL-5,
IL-13, IL-4, and IL-10 mRNA responses by real-time PCR at 8,
12, and 24 wk (Fig. 5C). As expected [35], there was a marked
increase in IL-4, IL-5, IL-10, IL-13, and IFN-c mRNA in the
livers of infected WT mice. However, consistent with the ICS
results, IL-13 mRNA levels were significantly reduced in the
CAT22/2 mice at all time points post-infection. Similar results
were seen with IL-4, although IL-5 mRNA was only slightly
reduced in the knockout mice. Also consistent with the ICS
studies, IFN-c mRNA expression was reduced in the CAT22/2
liver, but only significantly at the 8 wk time point. In contrast to
the other cytokines, IL-10 mRNA levels increased to a similar
extent in both groups at all time points post-infection. Together,
these results indicate that CAT2 expression ensures maximal
development of Th2 cytokine responses in vivo.
Proliferation of granuloma-associated effector T cells is
impaired in CAT22/2 mice
To explore mechanisms by which CAT2 regulates Th2
response development in vivo, we investigated whether the
proliferation of cytokine-producing cells was affected by CAT2
deficiency. Purified lymphocytes isolated from the granulomatous
livers (Fig. 6A) and mesenteric lymph nodes (Fig. 6B) were CFSE-
labeled and stimulated polyclonally with ConA for 72 hr.
Following stimulation, cells were assayed by intracellular cytokine
staining for IFN-c and IL-13, as markers of Th1 and Th2 effector
cells, respectively. In the liver (Fig 6A), there was significant
proliferation without additional ConA stimulation, indicating the
presence of a large population of antigen-activated T cells in the
granulomatous tissues of both WT and CAT22/2 mice. 34.7% of
the lymphocytes in the unstimulated WT group were also
producing IL-13, which increased to 45.1% after Con A
stimulation. The majority of the cytokine producing cells were
also proliferating (20.6% before and 33.1% after Con A
stimulation), indicating the presence of a large population of
effector Th2 cells in the infected WT liver. In contrast, only 21.1%
of the CAT22/2 lymphocytes were producing IL-13 and no
increase was observed after Con A stimulation. The CAT22/2 IL-
13-producing cells were also proliferating at a much slower pace
(8.5% before and 10.3% after ConA stimulation). Similar results
were seen for IFN-c (right panels), although in general there were
more IL-13 than IFN-c producers in the liver. The number of
proliferating IFN-c producing cells in WT liver was 24%, which
decreased to less than 5% in CAT22/2 mice (Con A stimulated),
demonstrating that both the proliferative and cytokine producing
capabilities of granuloma-associated lymphocytes were diminished
in the absence of CAT2. As expected, the frequency of cytokine
producing cells was much lower in the MLN (Fig. 6B). Moreover,
although the frequency of cytokine-producing cells increased
following Con A treatment, there were no significant differences
between the two groups, suggesting that the impaired cytokine and
proliferative responses of CAT22/2 mice were restricted to the
granulomatous tissues.
CAT2 Regulates Th1/Th2 Immunity
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In addition to Th1/Th2 cytokines, we also examined whether
FoxP3, IL-17, and TGF-b1 expression were altered in the infected
CAT22/2 mice. In contrast to the marked effect observed on Th2
cytokine expression, however, granuloma-associated CD4+ T cells
from CAT22/2 and WT mice displayed similar IL-17, FoxP3,
and TGF-b1 responses. In fact, the Th17 response was weak when
compared with the Th2 cytokine response. For example, at 9 wk
post-infection, the percentage of CD4+ T cells that were IL-13
positive was 17.1% and 11.8% in WT and CAT22/2 mice,
respectively, while only 0.19% and 0.2% were IL-17 positive.
Figure 2. CAT22/2 mice display increased granulomatous inflammation in the liver following infection with S. mansoni. WT C57BL/6
(open squares) and CAT22/2 (filled circles) mice were infected with 30–35 S. mansoni cercariae and sacrificed on wks 8, 12 and 24 post-infection. The
results shown are for individual mice pooled from 3 separate experiments. A. Liver granuloma volumes measured microscopically at 8, 12 and 24 wks
post-infection. The * symbol denotes significant differences between WT and KO mice at that time point, p,0.05. B. Percentage of liver granuloma-
associated eosinophils (% of total cells). C. Liver granuloma-associated mast cells (Scale 1–8). D. Representative granulomas from an infected WT
C57BL/6 mouse (wk 8 post-infection). Arrows indicate the perimeter of an individual granuloma with the miracidium containing egg in the center.
The bar in panel 2D = 200 microns. E. Representative granulomas from an infected CAT22/2 mouse. F. % Survival after infection with 100 cercariae.
p,0.001.
doi:10.1371/journal.ppat.1000023.g002
CAT2 Regulates Th1/Th2 Immunity
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Although we observed significant FoxP3 expression in the liver,
the responses in WT and CAT22/2 were again nearly identical,
with 6.87% of WT and 6.19% of CAT22/2 CD4+ T cells
expressing FoxP3. There were also no significant difference in
TGF-b1 mRNA expression in the livers of infected WT and
CAT22/2 mice (not shown).
Arginase activity is increased in CAT22/2 alternatively-
activated macrophages
Numerous studies have demonstrated that granuloma formation
and hepatic fibrosis are dependent on Th2 cytokines [26,29,36];
therefore, it was surprising to find a markedly reduced Th2
cytokine response in the granulomatous tissues of the CAT22/2
mice, since immunopathology increased significantly in these
animals. Because Arg-1 and iNOS activities are regulated by the
availability of L-arginine [17] and alternatively-activated macro-
phages play an important role in the pathogenesis of schistosomi-
asis [9,10], we examined whether CAT2 deficiency was regulating
the function of alternatively-(AA) or classically- (CL)-activated
macrophages. CAT2 mRNA levels were increased 20- to 40-fold
in both classically and alternatively activated macrophages,
suggesting that CAT2 activity is not restricted to a Th1- or
Th2-polarized response (Fig. 7A). CAT2 mRNA levels were also
increased over 10-fold in the granulomatous tissues of infected
mice (data not shown). Interestingly, however, when nitric oxide
and urea levels (a quantitative measure of arginase activity) were
measured, the NO producing ability of macrophages was
decreased in the absence of CAT2, regardless of the activation
stimuli used (Fig. 7B). In marked contrast, urea production was
significantly increased in alternatively-activated CAT22/2 mac-
rophages (Fig. 7C). IL-4, IL-13, IL-21, and GM-CSF have all been
shown to increase arginase activity in macrophages [13,37,38].
Interestingly, the CAT22/2 macrophages displayed enhanced
arginase activity with nearly every stimulus examined (Fig. 7D).
Finally, there were also significantly more macrophages in the
CAT22/2 granulomas (Fig 7E), suggesting that the increase in
granuloma size was due in part to the increased recruitment of
macrophages to the liver.
Fibroblast arginase activity is increased in the absence of
CAT2
Next we investigated fibroblast activity. For these studies,
primary fibroblasts were generated from lung tissue and in initial
studies, the production of NO and urea was compared in WT and
CAT22/2 fibroblasts following classical or alternative activation.
In contrast to classically activated macrophages, where NO
expression was only partly CAT2 dependent (Fig. 7B), production
of NO by CAT22/2 fibroblasts was almost entirely dependent on
CAT2 activity (Fig. 8A). Nevertheless, the amount of NO
produced by CL-activated fibroblasts was nearly ten-fold lower
Figure 3. S. mansoni infected CAT22/2mice develop exacerbated liver fibrosis. WT C57BL/6 (open squares) and CAT22/2 (filled circles) mice
were infected with 30–35 S. mansoni cercariae and sacrificed on wk 8, 12 and 24 post-infection. A. Liver Fibrosis adjusted per worm pair (mmol of
hydroxyproline/worm pair). The * symbol denotes significant differences between WT and KO mice at that time point, p,0.05. B. Liver Fibrosis per
10,000 eggs (mmol of hydroxyproline/16104 eggs). C. Representative liver granulomas stained with Masson’s Trichrome (8 wk infected C57BL/6
mouse). D. Representative liver granulomas stained with Masson’s Trichrome (8 wk infected CAT22/2 mouse). The bar in panel 3D = 200 microns.
doi:10.1371/journal.ppat.1000023.g003
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PLoS Pathogens | www.plospathogens.org 5 2008 | Volume 4 | Issue 3 | e1000023
than macrophages plated at the same density (Figs 7B and 8A).
Unlike macrophages, in which IFN-c/LPS was strictly required
for iNOS activity and IL-4/IL-13 for arginase activity (Fig. 7B and
7C), we observed significant spontaneous arginase activity in
primary fibroblasts. Indeed, unstimulated WT fibroblasts (Fig. 8B)
produced nearly the same amount of urea as alternatively-
activated WT macrophages (Fig. 7C). There was also no evidence
of enhanced arginase activity in fibroblasts following stimulation
with IL-4, IL-13, IL-21, or GM-CSF (Fig. 8B). Most striking
however, was the 4- to 5-fold increase in arginase activity in the
CAT22/2 fibroblasts. The CAT22/2 fibroblasts also proliferated
more rapidly, both spontaneously and in response to FGF
stimulation (Fig. 8C). In addition, production of IL-6, a key
cytokine in fibroblast proliferation and activation was also
increased in the CAT22/2 fibroblasts, both at baseline and in
response to IL-4/IL-13 stimulation (Fig. 8D). Consistent with these
in vitro observations, we detected significantly more fibroblasts in
CAT22/2 liver granulomas at both 8 and 12 wk post-infection
(Fig. 8E). Finally, to provide evidence that alternative activation
was increased in vivo, we injected WT and CAT22/2 mice
intravenously with 5000 viable S. mansoni eggs and examined the
expression of Arg1 and Retlna (RELM-a/Fizz1) mRNA in the
lung at 4 and 7 days post-injection. As shown in Figure 8F, both
genes associated with alternative activation were significantly
upregulated in the CAT22/2 lung. Finally, we also stained liver
sections from infected mice with antibodies to Arg1, alpha smooth
muscle actin (a-SMA), and F4/80, to characterize the pattern of
Arg1 expression in vivo. Consistent with the enhanced fibroblast
activity observed in vitro, the CAT22/2 granulomas showed
much greater staining for a-SMA, a marker of activated
myofibroblasts. They also displayed much stronger staining for
Arg1 and the overlay (purple staining) suggested that the majority
of Arg1 was associated with myofibroblasts, with lesser staining
observed in macrophages (Fig. 9).
Hepatic fibrosis in infected CAT22/2 mice is IL-13
independent
The IL-13 receptor alpha 2 functions as a decoy receptor for IL-
13 [39], and studies conducted with IL-13Ra22/2 mice
demonstrated that the decoy receptor inhibits the development
of hepatic fibrosis in schistosomiasis [40,41]. Because fibroblasts
are believed to be the key producers of sIL-13Ra2 and fibroblast
function was altered in the absence of CAT2 (Fig. 8), we measured
the circulating levels of IL-13Ra2 in infected CAT22/2 mice,
since changes in IL-13Ra2 expression might be contributing to
their exacerbated IL-13-associated pathologies. Surprisingly how-
ever, we found either similar, or at some time points, increased
levels of sIL-13Ra2 in the infected CAT22/2 mice (Fig. 8G).
Thus, despite displaying decreased IL-13 responses (Figs. 5–6) and
increased IL-13 decoy receptor levels (Fig. 8G), the CAT22/2
mice developed an exacerbated fibrotic response.
Next, to determine whether the severe liver pathology in the
infected CAT22/2 mice was in fact dependent on IL-13, we
infected WT and CAT22/2 mice with S. mansoni and inhibited IL-
13 with a neutralizing mAb. As expected [26], IL-13 blockade
significantly decreased fibrosis in WT mice (Fig. 10A) without
affecting the overall magnitude of the granulomatous response
(Fig. 10B). Surprisingly however, IL-13 blockade was completely
ineffective in CAT22/2 mice (Fig. 10A), suggesting that their
fibrotic response was independent of IL-13 activity. Importantly,
similar numbers of eggs and paired adult parasites were found in
the tissues of all groups (Table S2).
CAT2 augments Th1-dependent immunity by regulating
nitric oxide production
In a final series of experiments, we investigated whether CAT2
is required for the development of Th1-dependent immunity, since
NO production was impaired in CAT22/2macrophages (Fig. 7B),
as well as in fibroblasts (Fig. 8A). In these studies, the Toxoplasma
gondii model was used, since resistance is known to be mediated by
an IFN-c and NO-dependent mechanism [42]. Initially, we
Figure 4. S. mansoni infected CAT22/2 mice develop marked
hepatomegaly. A. Serum aspartate transaminase (AST) values in WT
C57BL/6 and CAT22/2 mice (wk 0, 8, 12 post-infection). The * symbol
denotes significant differences between WT and KO mice at that time
point, p,0.05. B. Serum alanine transaminase (ALT) values. C. Liver size
as percentage of body weight at 6, 8, 12, and 24 wk post-S. mansoni
infection.
doi:10.1371/journal.ppat.1000023.g004
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Figure 5. TH1/TH2 cytokine responses are reduced in infected CAT2
2/2mice. A. Leukocytes derived from the granulomatous livers of 8 wk
S. mansoni infected mice were stimulated with PMA/Ionomycin/BFA for 3 hr and then stained for CD4, IFN-c, IL-5 and IL-13. The data show the
percentage of CD4+ lymphocytes producing a specific cytokine. Results for individual mice are shown and statistically significant differences are
indicated in the figure. B. Frequency of non-CD4+ lymphocytes producing specific cytokines. C. Relative mRNA levels of ifn-c, il-5, il-13, il-4, il-10 in S.
mansoni infected liver tissue were determined by real-time Q-RT-PCR (wk 8,12 and 24), by normalizing mRNA levels to expressed, endogenous HPRT
mRNA. Fold increases in relative mRNA levels were determined by the ratio of normalized infected mRNA to uninfected mRNAs. Results from
individual mice are shown. The * symbol denotes significant differences between WT and KO mice at that time point, p,0.05.
doi:10.1371/journal.ppat.1000023.g005
CAT2 Regulates Th1/Th2 Immunity
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examined whether susceptibility was altered in the CAT22/2 mice
by monitoring host survival following infection with T. gondii. IFN-
c2/2 and NOS22/2 mice were included as controls. As expected,
WT mice were much more resistant than either IFN-c2/2 and
NOS22/2 mice, with approximately 50% of the WT animals
surviving through day 50 (Fig. 11A). In contrast, 100% of the IFN-
c2/2 and NOS22/2 mice succumbed between days 7–10 post-
infection, while CAT22/2 animals displayed an intermediate
phenotype, with 100% mortality observed by day 42. We also
infected WT and CAT22/2 mice and isolated peritoneal exudate
cells (PECs) on day 7 to quantify the number of infected cells and
to examine IFN-c and NO responses ex vivo. Consistent with their
enhanced susceptibility, the percentage of infected cells increased
in the CAT22/2 mice (Fig. 11B). This was also associated with a
significant increase in IFN-c production, both at baseline and
following stimulation with soluble T. gondii antigen (STAG).
Nevertheless, despite displaying much stronger IFN-c responses,
production of NO was markedly decreased in the CAT22/2
PECs, which likely explains their enhanced susceptibility.
Discussion
Previous studies have suggested that CAT2 controls NOS2 and
arginase activity by regulating arginine transport into cells [43],
however the relative importance of CAT2 in the development of
Th1 and Th2 effector functions was not investigated. Here, we
examined the role of CAT2 encoded by the Slc7a2 gene in vivo by
studying two well-established infectious disease models, character-
ized by the development of either protective Th1- or pathogenic
Th2-type immune responses [5,42]. We found that CAT2-
deficient mice were significantly more susceptible to the Th1-
inducing pathogen T. gondii. The increased susceptibility was
attributed to the attenuated NO response, which led to
uncontrolled parasite replication. When CAT22/2 mice were
Figure 6. Cytokine production and proliferation of CD4+ lymphocytes is impaired in the granulomatous tissues of infected CAT22/2
mice. A. Leukocytes derived from the granulomatous livers of 8 wk infected WT C57BL/6 and CAT22/2 mice were stained with CFSE and cultured for
72 hrs in the presence of media alone or Con A (1 mg/ml). Cells were subsequently stained for IL-13 (left panels) and IFN-c (right panels).
Representative FACS plots are shown. The experiment was repeated numerous times with similar results. B. Mesenteric lymph node cultures from
8 wk S. mansoni infected WT and CAT22/2 mice.
doi:10.1371/journal.ppat.1000023.g006
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challenged with the Th2-inducing pathogen S. mansoni, the animals
developed significantly worse Th2-associated pathology, despite
displaying weaker Th2 responses. Importantly, the pathological
changes in the CAT22/2 mice were associated with increased
arginase activity in fibroblasts and alternatively activated macro-
phages. These results reveal an essential role for CAT2 in the
development of Th1 immunity. However, they also suggest that
CAT2 functions as a potent negative regulator of Th2-associated
pathology, most likely by limiting arginase activity in important
effector cells like fibroblasts and macrophages.
NO production by iNOS contributes to normal cellular
processes, resistance to intracellular pathogens, and pathophysio-
logical conditions [23,44]. MacLeod and colleagues found that
CAT2 is induced coordinately with iNOS in numerous cell types
and studies conducted with CAT2-deficient cells demonstrated
that arginine uptake via CAT2 is required for sustained NO
production in macrophages [25] and to a lesser extent in astrocytes
[45]. However, NO synthesis in fibroblasts was only partially
dependent on CAT2, suggesting that other compensating
transporters can provide arginine for iNOS-mediated NO
synthesis [46]. Thus, the dependence on CAT2-mediated L-
arginine transport for NO production appears to vary in different
cell types. Moreover, the relative importance of CAT2 in the
development of NO-dependent immunity in vivo was previously
unknown.
To evaluate the function of CAT2 in vivo, we infected CAT22/
2 mice with the intracellular pathogen T. gondii. Resistance to T.
gondii is mediated by an IFN-c and NOS2-dependent mechanism
[42]. Therefore, we compared CAT22/2 mice with IFN-c- and
NOS2-deficient animals, since they are known to rapidly succumb
to T. gondii infection. Interestingly, despite developing a signifi-
cantly stronger IFN-c response (due to the higher parasite
burdens), the CAT22/2 mice were much more susceptible to T.
gondii, with all animals succumbing within 6 weeks. The increased
susceptibility was associated with a markedly attenuated NO
response, suggesting that CAT2 is critically important to the
development of Th1-associated immunity. However, the fact that
NOS22/2 mice died earlier than the CAT22/2 animals suggests
that NO synthesis in vivo is only partly dependent on CAT2. This
was consistent with the reduced but not completely ablated NO
responses of CAT22/2 peritoneal exudate cells.
Since NOS2 and Arg-1 both require L-arginine as a substrate
[1], we hypothesized that CAT2 might also regulate important
Th2 effector functions. Recent in vitro studies with bone marrow-
derived macrophages demonstrated that CAT2 is induced by both
Th1- and Th2-type stimuli [43,47], which was consistent with our
Figure 7. CAT22/2 BMMw display increased arginase activity but reduced NO responses. A. Messenger RNA for CAT2 is induced in BMMw
following classical (CL) or alternative activation (AA). BMMw were incubated with medium alone (MED), IFN-c/LPS (100 U/ml/100 ng/ml, CL), or IL-13/
IL-4 (20 ng/ml, AA) for 1–6 hrs. Total RNA was isolated from individual wells and CAT2 expression was analyzed by RT-PCR. The supernatants were
also collected. B. NO expression by activated CAT22/2 BMMw is impaired following classical (IFN- c/LPS) or alternative activation (IL-13/IL-4).
Supernatants were assayed for nitrate levels 24 and 48 hr post-stimulation. C. Urea production (a measure of arginase activity) was assessed in WT
and CAT22/2 BMMw’s following stimulation with CL or AA stimuli. D. CAT22/2 BMMw display increased arginase activity when exposed to multiple
‘‘alternative’’ activating stimuli. WT and CAT22/2 macrophages were stimulated with various combinations of IL-21, GM-CSF, IL-4 and IL-13 (all 20 ng/
ml). E. Macrophages in granulomas at 8 and 12 wk post-infection with S. mansoni (% adjusted proportionally by granuloma size). Spots represent the
mean of 30 granulomas analyzed per mouse.
doi:10.1371/journal.ppat.1000023.g007
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Figure 8. CAT22/2 primary fibroblasts display increased proliferative responses and spontaneous arginase activity. A. WT C57BL/6
(open bars) and CAT22/2 (filled bars) primary lung fibroblasts were stimulated with medium alone, IFN-c/LPS (100 U/ml/100 ng/ml, CL), or with IL-4/
IL-13 (20 ng/ml, AA). After 24 hr, NO activity was quantified by measuring nitrate levels in the supernatants. B. WT and CAT22/2 fibroblasts were
plated at 56105 cells per well and stimulated with various type-2 cytokines that promote alternative activation. Arginase activity was quantified by
measuring urea production (mg/dL). C. WT and CAT22/2 fibroblasts were plated at 16 105 cells/well, stimulated with medium alone or 50 ng/ml
FGFb, and proliferation was measured by (H3) thymidine incorporation. D. WT and CAT22/2 fibroblasts were plated at 16105 cells/well and cultured
in the presence of medium alone or IL-4/IL-13 (20 ng/ml). After 24 hr incubation, the supernatants were assayed for IL-6. All assays were repeated
with similar results. E. Fibroblasts in granulomas at 8 and 12 wk post-infection with S. mansoni (% adjusted proportionally by granuloma size). Spots
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observations. Moreover, studies conducted with macrophages
showed that L-arginine transport is significantly impaired in the
absence of CAT2, regardless of the stimuli used to activate the cells
[47]. Thus, it was suggested that CAT2 regulates both the classical
and alternative activation of macrophages [43]. Because Th2-
driven alternative macrophage activation plays a critical role in the
pathogenesis of schistosomiasis [9,10], we investigated the function
of the CAT2 gene in the murine model of schistosomiasis.
Strikingly, although CAT2 deficiency did not affect the establish-
ment of S. mansoni infection, Th2-associated pathology in the liver
was exacerbated and the animals died at a significantly accelerated
rate when compared with WT mice. Indeed, granuloma size
increased more than 3-fold and development of hepatic fibrosis
was exacerbated. Similar results were also obtained with the S.
mansoni pulmonary granuloma model.
Because granuloma formation and fibrosis are driven by the
Th2 cytokine response [7,10,26,27,29,35,36,48], we initially
examined whether CAT22/2 mice were developing stronger
Th2 responses. Unexpectedly, despite displaying a significant
increase in Th2-associated pathology [6], the frequency of
cytokine-producing CD4+ Th2 cells was markedly reduced in
the livers of the infected CAT22/2 mice (Fig. 5A). The granuloma
associated CD4+ Th2 lymphocytes also proliferated less when
restimulated in vitro. Together, these results indicate that CAT2 is
required for the maximal development of Th2 responses. Thus,
the severe pathological changes in the CAT22/2 mice were
paradoxically associated with reduced rather than enhanced Th2
cytokine production.
Previous studies with IL-4Ra2/2 and some IL-4-deficient mice
demonstrated that development of the Th2 response is critical for
survival in schistosomiasis, especially during the early stages of
infection [10,27,49,50]. In addition, recent studies with macro-
phage/neutrophil-specific IL-4Ra-deficient mice suggested that
the development of alternatively activated macrophages, in
particular, is critically important for host survival. [10]. Despite
developing significantly weaker Th2 responses, however, the
CAT22/2 mice showed no signs of increased susceptibility to S.
mansoni when infected with a low dose of parasites, with all of the
knockout animals successfully establishing chronic infections.
Moreover, in contrast to infected IL-4Ra and LysM(Cre)IL-
4Ra(2/flox) animals [10], the CAT22/2 mice did not default to
a Th1-type immune response. They also displayed no evidence of
significant hepatoxicity as determined by their serum AST/ALT
responses. In fact, liver enzymes were slightly reduced in the
CAT22/2 mice when compared with infected WT animals. These
data, when combined with the histological findings discussed
above, suggest that alternative macrophage activation is not
significantly impaired in the infected CAT22/2 mice. In fact,
evidence was obtained both in vitro and in vivo that alternative
activation increased in the absence of CAT2.
To investigate this hypothesis further, we stimulated WT and
CAT22/2 bone marrow-derived macrophages with cytokines that
are known to promote alternative macrophage activation
including, IL-4, IL-13, IL-21, and GM-CSF [13,37,38] and
examined the induction of arginase activity, a key feature of
AAMøs [1,51,52]. As expected, the Th2-associated cytokines
triggered significant arginase activity in WT macrophages.
However, the macrophages generated from CAT22/2 mice
consistently displayed a markedly exaggerated response. These
data demonstrate that CAT2 functions as a negative regulator of
arginase activity in macrophages, which may in part explain their
exacerbated fibrotic response. Thus, although it was recently
suggested that CAT2 could regulate both the classical and
alternative activation of macrophages [43], our combined in vitro
and in vivo data indicate that the primary role of CAT2 is to
optimize NO production in classically-activated macrophages,
while limiting arginase activity in alternatively-activated cells. The
maintenance of arginine transport by the constitutive arginine
transporter CAT1 could explain the preservation of arginase
activity in the CAT22/2 mice.
represent the mean of 30 granulomas analyzed per mouse. F. WT and CAT22/2 were sensitized with 5000 live S. mansoni eggs i.p. and then
challenged 2 wk later with 5000 eggs i.v. On day 4 and 7 post-challenge, lung tissue was harvested and Arg1 and Retlna mRNA expression was
quantified by real-time PCR and graphed as fold-increase over naı¨ve lung. The results for individual mice are shown. G. WT C57BL/6 (open squares)
and CAT22/2 (filled circles) mice were infected with S. mansoni cercariae and serum was collected at various time points post-infection. Serum IL-
13Ra2 levels were measured by ELISA in individual mice. The * symbol denotes significant differences between WT and KO mice at that time point,
p,0.05.
doi:10.1371/journal.ppat.1000023.g008
Figure 9. Arg-1 and a-SMA expression colocalized in CAT22/2 liver granulomas. C57BL/6 and CAT22/2 mice were infected percutaneously
with S. mansoni for 10 weeks. Portions of livers were removed and frozen. 8 mM liver sections from C57BL/6 and CAT22/2 mice were stained anti-F4/
80-Alexa 488 (Green), anti-Arg1-Alexa 647(Red), and anti-Alpha Smooth Muscle Actin-Texas Red (Blue). Individual 206 images were taken for each
channel and then combined to provide a composite image. Images are representative of 3 individual mice from independent experiments.
doi:10.1371/journal.ppat.1000023.g009
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Although alternatively-activated macrophages are believed to be
important regulators of wound healing and fibrosis [1,5],
fibroblasts are the primary collagen secreting cells. While it was
previously shown that CAT2 has only minimal effect on NO
production in classically-activated fibroblasts [46], the effects of
CAT2-deficiency on arg1 activity was not examined. To
determine whether CAT2 regulates fibroblast activation, we
generated primary lung fibroblasts from WT and CAT22/2 mice
and stimulated the cells with various Th1 or Th2-type stimuli.
Surprisingly, although classically-activated fibroblasts were in
general less potent producers of NO than macrophages, we
observed a significant (.75%) reduction in NO production in
CAT22/2 fibroblasts. In combination with earlier studies focused
on embryonic fibroblasts that reported a minimal (,20%) effect
Figure 10. Development of hepatic fibrosis in infected CAT22/2 mice is IL-13-independent. WT C57BL/6 (squares) and CAT22/2 (circles)
mice were infected with 30–35 cercariae. Separate groups were treated with either control antibody (C Ig, open symbols) or with a neutralizing mAb
to IL-13 (a-IL-13, filled symbols) weekly for a total of 4 wk starting on wk 5 post-infection. The animals were sacrificed on wk 9 and fibrosis and
granuloma formation were assessed. A. Liver hydroxyproline levels in individual mice, shown as mmol/liver, mmol/worm pair, and mmol/10K eggs.
Significant differences are indicated in each figure. B. Granuloma size (volume, mm361023), percentage of granuloma-associated eosinophils, and
mast cell indices were determined microscopically.
doi:10.1371/journal.ppat.1000023.g010
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on NO production [46] , our data suggest the dependence on
CAT2 for NO synthesis varies in different fibroblast subpopula-
tions.
We also examined the effects of CAT2 deficiency on arginase
activity. In contrast to macrophages, however, where arginase
activity was strictly dependent on Th2 cytokine stimulation,
fibroblasts displayed no significant cytokine inducible arginase
response, even when stimulated with an optimal combination of
Th2-type cytokines [37,38]. Nevertheless, when arginase activity
in WT and CAT22/2 fibroblasts was compared, the CAT22/2
fibroblasts exhibited much greater arginase activity at baseline.
The fibroblasts from CAT22/2 mice also proliferated faster and
produced significantly more of the autocrine growth factor IL-6
[53], both before and after stimulation with IL-4 and IL-13
[54,55,56]. Thus, the enhanced arginase activity in CAT22/2
fibroblasts and AAMø’s likely contributed to their exacerbated
inflammatory and fibrotic responses following infection with S.
mansoni. The increased arginase response may also explain the
suppressed CD4+ Th2 cell responses in the granulomatous tissues.
Because T cells, macrophages, and fibroblasts all compete for
arginine, the increased arginase activity in CAT22/2 macrophag-
es and fibroblasts may have reduced arginine levels in the
granulomatous tissues, resulting in the local suppression of CD4+
T cell responses, as has been postulated recently in related studies
[17,57,58]. In contrast to classically activated macrophages,
AAMø’s are also known to be inefficient stimulators of T cell
proliferation [59], with F4/80+ alternatively activated macrophag-
es functioning as potent inhibitors of antigen-specific CD4+ T cell
proliferative responses in vivo [58].
Fibroblasts are also important producers of the soluble IL-
13Ra2 [40,60], which can function as a decoy receptor for IL-13
and was recently shown to inhibit the development of fibrosis in
Figure 11. Development of Th1 immunity is compromised in CAT22/2mice. A. WT C57BL/6 (open squares), CAT22/2 (filled circles), NOS22/2
(filled inverted triangles) and IFN-c2/2 (filled triangles) mice were infected i.p. with 20 T. gondii cysts, and survival was assessed up to 50 days
post-infection. (N = 5/group). B. Peritoneal exudate cells (PECs) were prepared from WT and CAT22/2 mice on day 7 post-infection. The
percentage of infected cells was determined microscopically by evaluating a minimum of 700 cells per slide (3 mice/group). C. PECs were
placed in culture for 24–48 hr and either left untreated or restimulated with STAG. Culture supernatants were collected and IFN-c levels were
determined by ELISA. D. NO activity was evaluated in the same culture supernatants by measuring nitrate production.
doi:10.1371/journal.ppat.1000023.g011
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schistosomiasis [39,40,41]. Since CAT2 fibroblasts displayed an
unusual activated phenotype, we examined whether production of
the sIL-13Ra2 was also altered in the CAT22/2 mice. Decreased
production of the sIL-13Ra2 could provide a simple and
straightforward explanation for their exacerbated IL-13-driven
pathological responses. Surprisingly, the exact opposite was
observed. Indeed, serum levels of sIL-13Ra2 were either the
same or slightly increased in the infected CAT22/2 mice. Thus,
we questioned whether the development of fibrosis in CAT22/2
mice was in fact dependent on IL-13. To formally address this
question, we performed a series of studies with neutralizing
antibodies to IL-13 [61]. Strikingly, although IL-13 blockade had
a highly significant anti-fibrotic effect in WT mice, CAT22/2
mice were unresponsive. These observations, when combined with
the reduced IL-13 and enhanced IL-13Ra2 responses, suggest that
the development of fibrosis in CAT22/2 mice is to a large extent
IL-13-independent.
When viewed together, the data point to fibroblasts and
AAMø’s as the key mediators of the exacerbated pathological
response, since arginase activity was increased in the CAT22/2
cells. In the case of fibroblasts, the enhanced arginase response also
appeared to be independent of Th2 cytokine stimulation. Arg1
and a-SMA expression also colocalized in the granulomatous
livers and both proteins were expressed at much higher levels in
the infected CAT22/2 mice, confirming that there were more
activated myofibroblasts. However, there was no evidence of
spontaneous liver fibrosis in uninfected CAT22/2 mice, suggest-
ing that a chronic inflammatory stimulus or some type of tissue
damage was needed to initiate the fibroproliferative response.
Nevertheless, a recent study found that CAT2-deficient mice are
susceptible to the development of spontaneous inflammation in the
lung [62]. The same group also showed that CAT2 expression is
linked with the development of asthma [63]. Thus, mucosal
tissues, which are repeatedly exposed to irritants, may be
particularly sensitive to changes in CAT2 activity. As such,
CAT2 may be involved in the regulation of a wide variety of
diseases that are normally associated with chronic Th2 responses.
In conclusion, these studies demonstrate for the first time that
CAT2 is critically important for the development of IFN-c/NO-
dependent immunity to the intracellular protozoan pathogen T.
gondii. In addition, by inhibiting arginase activity in fibroblasts and
alternatively-activated macrophages, CAT2 functions as a power-
ful negative regulator of type-2 cytokine-driven pathology. Thus,
these findings may have major implications for a wide variety of
infectious and inflammatory diseases.
Materials and Methods
Mice, parasite infections, and antigen preparation
Female C57BL/6 were obtained from Taconic Farms (German-
town, NY) [64]. Breeding pairs of C57BL/6 CAT22/2 mice were
obtained from the UCSD Cancer Center (La Jolla, CA) [25]. Mice
were housed under specific pathogen-free conditions at the
National Institutes of Health in an American Association for the
Accreditation of Laboratory Animal Care approved facility. The
NIAID animal care and use committee approved all experimental
procedures. S. mansoni eggs were extracted from the livers of
infected mice (Biomedical Research Institute, Rockville, MD) as
previously described [35]. For the induction of secondary
granulomas, mice were sensitized intraperitoneally (i.p.) with
5000 live eggs, and then challenged with 5,000 live eggs i.v [31]. In
the infection experiments, mice were infected percutaneously via
the tail with 30–35 cercariae of a Puerto-Rican Strain of S. mansoni
(NMRI) obtained from infected Biomphalaria glabrata snails
(Biomedical Research Institute). Soluble egg Antigen (SEA) was
obtained from purified and homogenized S. mansoni eggs [33]. All
animals underwent perfusion at the time of sacrifice so that worm
and tissue egg burdens could be determined [33]. 20 cysts of the
avirulent ME49 strain were inoculated i.p into C57BL/6,
CAT22/2 , NOS22/2 (Taconic), and IFN-c2/2 (Taconic) mice
for morbundity studies. In some studies, mice were sacrificed day 7
post-inoculation and PECs were harvested and set up in culture for
24 and 48 hours in media and with soluble tachyzoite Ag (Stag),
which was prepared as described [65].
Histopathology and fibrosis
The sizes of pulmonary and hepatic granulomas were
determined on histological sections that were stained with Wright’s
Giemsa stain (Histopath of America, Clinton, MD). Approximate-
ly 30 granulomas per mouse were included in all analyses. A skilled
pathologist evaluated the percentages of eosinophils, mast cells,
and other types of cells in the same sections. The number of
schistosome eggs in the liver and the gut and the collagen content
of the liver, as measured by hydroxyproline levels, were
determined as previously described [33]. Specifically, hepatic
collagen was measure as hydroxyproline by the technique of
Bergman and Loxley [66]. The increase in hepatic hydroxyproline
was positively related to egg numbers in all experiments and
hepatic collagen is reported as the increase above normal liver
collagen in mmoles per 10,000 eggs; (infected liver collagen –
normal liver collagen)/liver eggs61024 or mmoles per worm pair.
At late chronic time points, fibrosis is reported as total liver
collagen per liver. The same individual scored all histological
features and had no knowledge of the experimental design.
Flow cytometry, cell isolation, proliferation assays, and
ICC
Mesenteric lymph nodes (MLN) and about 200 mg of
granulomatous liver tissue was disrupted into single cell suspension
by grinding through a 100 mm nylon mesh. The WBCs from liver
cells were separated on a 34% percoll gradient (350 g for 20 min)
(Fluka). MLN and Liver WBCs were treated with 2 ml of ACK
lysis buffer (Quality Biological) for 2 min. Purified leukocytes were
stained with 5 mM CFSE (Molecular Probes) for 5 min at RT.
Excess CFSE was quenched by washing the cells in RPMI
supplemented with 10% FBS. 36106 cells were cultured in 24 well
plates and were either left unstimulated or stimulated with 1 mg/
ml of Con A for 72 hours. (note, the WBCs separated from the
liver contain live S. mansoni eggs and therefore all liver leukocyte
cultures are exposed to soluble egg antigens as well). ICC: Liver
leukocytes either freshly isolated (ex vivo) or restimulated for
72 hrs were stimulated with PMA (10 ng/ml), Ionomycin (1 mg/
ml) and BFA (10 mg/ml) (Sigma) for 3 hrs. Cells were surface
stained for CD4 PE-Cy5 (BD Biosciences), fixed in 2%
formaldehyde for 20 min at RT, permeabolized with 0.1%
saponin buffer (Sigma) and stained for IFN-c (APC or FITC),
IL-5 APC (BD Biosciences) and IL-13 PE (Centocor) and acquired
with FACS CaliburH. Data were analyzed in FlowjoH V8.
RNA isolation and real time polymerase chain reaction
Lung and liver tissue samples were placed individually in 500 ml
of RNAlater and frozen at 220uC (Ambion). Samples were
removed from RNAlater and placed in 500 ml TRIzol reagent
(Invitrogen) to purify RNA. Total RNA was further purified using
RNeasy Mini Kit from Qiagen (Qiagen Sciences). RNA (1 mg) was
reverse-transcribed using Superscript II (Invitrogen, Carlsbad, CA)
and quantification of transcripts was performed using Applied
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Biosystems (Foster City, CA) pre-designed gene expression assays
for IFN-c, IL-5, IL-13, IL-4, and IL-10. Each Taqman assay was
run in duplicate. For each sample 5 ul of a 1:30 dilution of cDNA
reaction cocktail in a 20 ul final volume TaqMan reaction was
used for each assay. Reaction preparation and thermal cycling
were carried out following the manufacturer’s protocol with a
modification of increasing qPCR cycles to 50. Assay samples were
normalized to HPRT expression and compared to uninfected
controls according to comparative CT method (Applied Biosys-
tems).
Bone marrow derived macrophages
Bone marrow was recovered from female C57BL/6 and
CAT22/2 mice and cultured in Petri dishes (100 6 15 mm)
containing supplemented DMEM media (20% L929 conditioned
medium) for a period of 6 days. After six days cells were harvested
and seeded at a concentration of 5 6 105 cells/well in 24 well
plates containing supplemented DMEM media (10% FBS, 2 mM
L-glutamine, 100 U/mL penicillin, and 100 ug/mL streptomy-
cin). Cells were stimulated for 16 hr with combinations of IL-4, IL-
13, and GMCSF (20 ng/ml), IFNc (100 U/mL), or LPS (100 ug/
mL)( Peprotech). In some cases, the cells were pretreated with IL-
21 (R&D) for a period of 6 hr. Supernatants were collected for NO
analysis and cells were lysed for arginase activity and RNA
isolations. Real-time RT-PCR was performed on an ABI PRISM
7900HT Sequence Detection System (Applied Biosystems).
Relative quantities of mRNA was determined using SYBR Green
PCR Master Mix (Applied Biosystems) and by the comparative
threshold cycle method. In this method, mRNA levels for each
sample were normalized to hypoxanthine guanine phosphoribosyl
transferase (HPRT) mRNA levels and then expressed as a relative
increase or decrease compared with levels in media only controls.
Primers were designed using Primer Express software (version 2.0;
Applied Biosystems). Primers for CAT2-F CTC CTG GGT GCT
CTG AAC CA and CAT2-R CTT CTC CCC TCC CGT TGA
AC.
Primary lung fibroblasts
Whole lungs were harvested in cRPMI supplemented with 10%
FBS (Hyclone), 2 mM- L-Glutamine, 100 mg/ml penicillin–
streptomycin (Gibco), 50 uM ß-mercaptoethanol (Sigma), minced
into small pieces, and exposed to Collagenase D (1 mg/ml)
(Roche) and 4 U/ml DNase I (Sigma) for 40 mins at 37uC with
shaking. Tissues were disrupted by straining through a 100 micron
nylon mesh (BD Falcon). The single cell suspensions were plated in
Iscove’s Modified Dulbecco’s Medium with 2 mM L-glutamine,
5% FCS, 25 mM HEPES, 100 mg/mL Streptomycin, 100 U/mL
Penicillin, 50 uM 2-ME. (3 lungs plated on 3–100615 mm Petri
dishes). 50% of media was changed on day 7 and cells were
recovered on day 14 by adding 4 mL of HyQtase (Hyclone)
reagent for 20 min and rigorously pipetting repeatedly to remove
cells. Cells were then cultured at 5 6 105 cells/well in 24 well
plates. After activation with cytokines, supernatants were collected
for NO analysis and IL-6 determination. Other cells were lysed to
determine arginase activity or cultured for fibroblast proliferation.
Enzyme-Linked Immunosorbent Assay (ELISA)
IL-13Ra2 levels were determined by ELISA as previously
described [41]. The concentration of IL-13Ra2 in the sample was
determined from a serial-fold diluted standard of rmIL-13Ra2 Fc/
chimera (R & D Systems). The sensitivity of the assay was approx.
98 pg/ml. IL-6 levels were measured using murine IL-6 DuoSet
ELISA Development System (R&D Systems) according to the
manufacturer’s protocol. IFN-c was assayed by sandwich ELISA,
as previously described [41], and quantitated by comparison with
standard curves generated with rIFN-c (provided by Genentech,
San Francisco, CA, and Genetics Institute, Cambridge, MA,
respectively).
Nitrite analysis and arginase assays
The concentration of nitrite in supernatants of primary lung
fibroblasts and bone-marrow derived macrophages stimulated in
vitro was determined spectrophotometrically by using the Griess
reagent. Supernatants were collected after 16 hours, mixed 1/1
with Griess reagent, and absorbance measured at 543 nm using a
SpectraMax 190 (Molecular Devices, Sunnyvale, CA). The nitrite
concentration was determined using sodium nitrite as standard. In
the arginase assays, cells were plated at 56105 per well in 96 well
tissue culture plates and stimulated with combinations of IL-4, IL-
13, and IL-21 (20 ng/mL). IL-21 was added 6 hours prior to IL-4
or IL-13 stimulation. Following stimulation, cells were washed
with PBS and lysed with 0.1% TritonX-100 containing protease
inhibitor (Roche). Lysates were transferred into a 96 well PCR
plate and incubated with 10 mM MnCl2 and 50 mM Tris HCl
(pH 7.5) to activate enzyme for 10 min at 55uC. After enzyme
activation, 25 ml of lysate was removed and added to 25 ml 0.5 M
arginine (pH 9.7) in a new PCR plate and incubated for 1–2 hours
at 37 C. 5 ml of each sample was added in duplicate to a 96 well
ELISA plate along with 5 ml of each standard, diluted in same
assay conditions, starting at 100 mg/dL. Urea determination
reagent from BioAssay Systems Quantichrome Urea Assay Kit
was used according to the manufacturer’s protocol.
IL-13 blocking experiments
C57BL/6 (10/group) mice were infected percutaneously via the
tail with 30–35 S. mansoni cercariae. Beginning on wk 5 post-
infection, mice were treated with either mouse anti-IL-13 mAb
[61] or GL113 control antibody (Harlan Bioproducts). Each
mouse received one 0.5 mg dose/wk via i.p. injection on wk 5, 6, 7
and 8. Mice were sacrificed on wk 9 post-infection.
T. gondii infection studies
Acute tachyzoite growth was assessed using cytocentrifuge
smears of peritoneal cells as previously described [65]. Differen-
tial analyses, including assessment of intracellular T. gondii
infection, were performed on 700 or more cells per animal.
Single-cell suspensions were prepared from peritoneal exudates
and washed in CRPMI. Peritoneal cells were cultured at 2.5 6
106 cells/mL in 200 ml of RPMI 1640 supplemented with 10%
FBS, penicillin (100 U/ml), streptomycin (100 mg/ml), L-gluta-
mine (2 mM), HEPES (10 mM), and 2-ME (Sigma) in the
presence or absence of soluble tachyzoite Ag (5 mg/ml).
Supernatants were harvested 24 and 48 hr later for determina-
tion of levels of IFN-c and NO.
Cell proliferation assays
WT and CAT22/2 primary lung fibroblasts (1 6 105/well)
were plated in Iscove’s Modified Dulbecco’s Media in 96 well flat
bottom plates (BD Falcon) for 16 hr at 37uC. 1 mCi/well of
[3H]thymidine (Amersham) was added for 24–72 hrs. Cells were
frozen at 220 C and were later collected onto a glass fiber filter
pads (LKB Wallac, Turku, Finland) using a 96-well harvester
(Tomtec, Orange, CT). Scintillation cocktail was (XSC/9200;
LKB Wallac) added, and radioactivity determined on a liquid
scintillation counter (Betaplate model 1205, LKB Wallac). Some
cells were stimulated with FGFb at 50 ng/ml (Invitrogen). Each
sample was set up in triplicate.
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Fluorescent imaging and microscopy
8 um liver sections were taken from WT and CAT22/2 10 wk
S. mansoni infected livers. Sections were fixed in cold acetone for
10 minutes and stored at 220uC. Slides were washed 36 in DPBS
and incubated with F4/80 conjugated with Alexa 488 (Caltag
Clone CI:A3-1), Alpha Smooth Muscle Actin (Sigma-Aldrich
Clone 1A4) conjugated with Texas Red, and Arginase1 (Santa
Cruz Biotechnology Clone V-20) conjugated with Alexa 647.
Images were collected on a Leica SP5 confocal microscope (Leica
Microsystems, Exton, PA USA) using a 206 oil immersion
objective NA 0.70. Fluorochromes were excited using an Argon
laser for Alexa 488, an Orange Helium-Neon laser for Alexa 594
and a Red Helium-Neon laser for Alexa 647. To avoid possible
crosstalk the wavelengths were collected separately and later
merged. Images were processed using Leica LAS-AF software
(version 1.7.0 build 1111).
Statistics
Hepatic fibrosis (adjusted for egg number) decreases with
increasing intensity of infection (worm pairs). Therefore, these
variables were compared by analysis of covariance, using the
logarithm of total liver eggs as the covariate and the logarithm of
hydroxyproline content per egg. Variables that did not change
with infection intensity were compared by one-way ANOVA or
Student’s t test [33]. Changes in cytokine mRNA expression and
granuloma size were evaluated using ANOVA. Differences were
considered significant when p,0.05.
Supporting Information
Table S1 Worm and Egg Burdens
Found at: doi:10.1371/journal.ppat.1000023.s001 (0.04 MB
DOC)
Table S2 Worm and Egg Burdens
Found at: doi:10.1371/journal.ppat.1000023.s002 (0.03 MB
DOC)
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